Biomaterials and biofabrication in the Netherlands: state of the art in 2026

Authors:
  • EFEric Farrell
    Eric Farrell
  • MBMatthew B. Baker
    Matthew B. Baker
  • DKDavid Kilian
    David Kilian
  • LMLorenzo Moroni
    Lorenzo Moroni
  • FSFarhad Sanaei
    Farhad Sanaei
  • MDMani Diba
    Mani Diba
  • SLSander Leeuwenburgh
    Sander Leeuwenburgh
  • AZAmir A. Zadpoor
    Amir A. Zadpoor
  • CBCarlijn V. C. Bouten
    Carlijn V. C. Bouten
  • MDMonize Caiado Decarli
    Monize Caiado Decarli
  • PRPatrick van Rijn
    Patrick van Rijn

Abstract
Biomaterials and biofabrication are multidisciplinary and rapidly evolving fields that enable innovations that are crucial for addressing current healthcare challenges. The Netherlands has a broad, active, and collaborative research community that is developing advanced biomaterials and cutting.edge biofabrication methods, with applications in tissue engineering, regenerative medicine, in vitro disease modeling, and biomedical devices. Dutch researchers have pioneered advanced biofabrication, supramolecular and inorganic chemistry for creating biomaterials, organoids and organ-on-chip in vitro platforms, and regenerative medicine. This paper presents recent work on biomaterials and biofabrication and their applications from 11 prominent research institutions across the Netherlands, and it describes joint initiatives that target broader goals within the field. Contributors from each institution provide insights into recent progress, key scientific contributions, and forward-looking perspectives. By presenting the state-of-the-art research landscape, this article serves as a reference for scientists actively engaged in or planning to initiate biofabrication or biomaterials-related research, offering guidance on technology selection, experimental design, academic collaboration, and translational development.

This publication has 529 references indexed in Scilit: